Search - tctmd.com

Displaying 181 - 200 of 430

Sort: Relevancy | Date

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

Todd Neale

November 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Kwan S. Lee

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

Presentation TCT 2017

Reduction of In-stent Thrombus Immediately After PCI by Pretreatment With Prasugrel Assessed by OCT

Presenter: Takeshi Kimura, Shigeru Saito, Takashi Kubo

October 29, 2017

News Daily News

Leg Shields May Prevent Radiation-Induced DNA Damage During EVAR

L.A. McKeown

October 25, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Daily News

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Todd Neale

June 05, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

Advertisement

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

TCTMD’s Top 10 Most Popular Stories for November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Live From Denver: TCT 2017, Day Two

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Reduction of In-stent Thrombus Immediately After PCI by Pretreatment With Prasugrel Assessed by OCT

Leg Shields May Prevent Radiation-Induced DNA Damage During EVAR

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content